Intercure Ltd.INCR
Price (close)
$5.26
Market cap
$78.9M
P/E
—
Revenue (FY)
$238.8M
Net income
-$67.8M
Dividend yield
—
1-year total return
-26.9%
Net margin
-28.4%
Revenue growth
-32.8%
Debt / equity
0.29x
What Intercure Ltd. does.
operations are focused on the production (including the breeding, cultivating, importing and processing), manufacturing, exporting
Pharm Ltd.’s operations are focused on managing and operating a medical cannabis pharmacy in the commercial center (M-Haderh)
Global Ltd.’s operations are focused on managing and operating the Greenlog trade house which operates as a distributor of
Revenue and profit, by fiscal year.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | $8.9M | $65.0M | $219.7M | $388.7M | $355.6M | $238.8M |
| Net income | -$5.9M | -$37.2M | $4.7M | $44.8M | -$62.0M | -$67.8M |
| Free cash flow | -$39.7M | -$12.9M | $16.1M | $31.5M | -$56.3M | -$71.3M |
More on INCR.
- Intercure Ltd. summary
- Intercure Ltd. financial statements
- Intercure Ltd. key metrics
- Intercure Ltd. health scores and style box
- Intercure Ltd. earnings
- Intercure Ltd. dividends
- Intercure Ltd. valuation
- Intercure Ltd. ownership and insiders
- Intercure Ltd. peers
Figures from Intercure Ltd.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.